25 February 2015
NEW DELHI: The government will shortly come out with strategies to improve bulk drug manufacturing capacity in India in order to reduce dependence on China for import of bulk drugs.
"We are importing 70-80 per cent bulk drugs from China. We will shortly come out with strategies to improve our bulk drug capacity in India.
There was a time when India was producing bulk drugs in a big way and now nothing," Pharmaceuticals Secretary V K Su .. There was a time when India was producing bulk drugs in a big way and now nothing," Pharmaceuticals Secretary V K Subburaj said at an event organised by industry body Assocham.
He said the committee set up by the government has submitted its recommendations and the Department of Pharmaceuticals is examining it and will come out with its strategies shortly.
These strategies will be part of the proposed bulk drug pharma policy.
06 September 2024
NovaMedica expands its line of products for the treatment of Alzheimer’s disease
22 August 2024
Children visited the NovaMedica Innotech pharmaceutical manufacturing facility
14 June 2024
87% of cancer patients give positive ratings for medical care quality
18 September 2024
The Russian market of fillers and biorevitalizers grew by 21% in the first half of 2024
18 September 2024
Pharma’s Patient Reach Problem: Billions Still Left Behind
17 September 2024
17 September 2024